Stoke Therapeutics names Ian F. Smith as permanent CEO and principal executive
PositiveFinancial Markets

Stoke Therapeutics has appointed Ian F. Smith as its permanent CEO and principal executive, marking a significant step for the company as it continues to advance its mission in the biotechnology sector. This leadership change is expected to bring stability and vision to the organization, which is focused on developing innovative therapies for genetic diseases. Smith's experience and commitment to the company's goals are likely to enhance stakeholder confidence and drive future growth.
— Curated by the World Pulse Now AI Editorial System